-
-
-
-
-
-
-
Dianthus Therapeutics, Inc. Announces Proposed $400 Million Underwritten Public Offering
-
-
-
-
-
-
-
Guggenheim on Dianthus Therapeutics (DNTH): 'remains one of our Top Picks'
-
-
-
-
-
-
-
Guggenheim Starts Dianthus Therapeutics (DNTH) at Buy, sees $850M in Peak Sales for DNTH103
22,896 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

